Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Schlafen 12 Modulation and Targeting in Acute Myeloid Leukemia.
Journal: Cancer research communications
Published: May 27, 2025
FBXO11 suppression rewires an NPM1-centered interactome influencing the progression of myelodysplastic syndrome.
Journal: The Journal of clinical investigation
Published: April 02, 2025
Targeting SLFN11-regulated pathways restores chemotherapy sensitivity in AML.
Journal: Blood neoplasia
Published: January 22, 2024
LKB1/STK11 Is a Tumor Suppressor in the Progression of Myeloproliferative Neoplasms.
Journal: Cancer discovery
Published: September 23, 2020
FBXO11 is a candidate tumor suppressor in the leukemic transformation of myelodysplastic syndrome.
Journal: Blood cancer journal
Published: June 05, 2020
Myelofibrosis in 2019: moving beyond JAK2 inhibition.
Journal: Blood cancer journal
Published: December 17, 2018
The expanding role of venetoclax in chronic lymphocytic leukemia and small lymphocytic lymphoma.
Journal: Blood and lymphatic cancer : targets and therapy
Published: December 07, 2018
Evaluation of the impact of cachexia on clinical outcomes in aggressive lymphoma.
Journal: British journal of haematology
Published: November 22, 2018
Current overview and treatment of mantle cell lymphoma.
Journal: F1000Research
Published: July 18, 2018
TCA Cycle and Mitochondrial Membrane Potential Are Necessary for Diverse Biological Functions.
Journal: Molecular cell
Published: July 15, 2015
ROS function in redox signaling and oxidative stress.
Journal: Current biology : CB
Published: May 22, 2014
TOR signaling couples oxygen sensing to lifespan in C. elegans.
Journal: Cell reports
Published: March 03, 2014
Last Updated: 09/26/2026